Ind-Swift Laboratories Limited
INDSWFTLAB

Ind-Swift Laboratories Limited

Pharmaceuticals
Share price
₹317
Market cap
₹2,756 Cr
1Y return
▲ 215%

A pharmaceutical manufacturer engaged in the production of bulk drugs and formulations, Ind-Swift Laboratories operates across India's medicinal compounds sector. Established in 1995, the company focuses on developing and supplying active pharmaceutical ingredients and finished dosage forms to both domestic and international markets. Its integrated operations span research, manufacturing, quality control, and distribution within the broader pharmaceutical value chain.

Investors holding Ind-Swift Laboratories Limited

NG
Nova Global
Foreign Investor
3.32%

Recent moves 5

Nova GlobalIncreased
Nova Global increased its stake in Ind-Swift Laboratories from 2.96% to 3.32%, acquiring 3,15,115 shares through a rights issue.
15 Oct 2026
Read more
Essix Biosciences LimitedIncreased
Essix Biosciences Limited and its persons acting in concert increased their stake in Ind-Swift Laboratories Limited from 43.06% to 47.18%, acquiring 70,00,000 fully convertible warrants on a preferential basis.
17 Sept 2026
Read more
Nova GlobalNew position
Nova Global entered Ind-Swift Laboratories with 25,72,991 shares, a 2.96% stake.
21 Jul 2026
Read more
Nova GlobalNew position
Nova Global bought 803,387 shares of Ind-Swift Laboratories for ₹11.09 Cr at ₹138.07 apiece in a bulk deal.
17 Apr 2026
Read more
Sahastraa AdvisorsNew position
Sahastraa Advisors bought 4,75,000 shares of Ind-Swift Laboratories for ₹6.26 Cr at ₹131.74 apiece in a bulk deal on April 17, 2026.
17 Apr 2026
Read more

Track the whales in Ind-Swift Laboratories Limited

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1